An Open-label Study of the Safety and Efficacy of Tag-7 Gene-modified Tumor Cell-based Vaccine in Patients With Locally Advanced or Metastatic Malignant Melanoma or Renal Cell Cancer
Conditions: Melanoma; Kidney Cancer Intervention: Biological: Tag-7 gene modified inactivated tumor cells Sponsors: N.N. Petrov National Medical Research Center of Oncology; Institute of Gene Biology Russian Academy of Sciences Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Biology | Cancer | Cancer & Oncology | Cancer Vaccines | Genetics | Kidney Cancer | Melanoma | Renal Cell Carcinoma | Research | Russia Health | Skin Cancer | Study | Urology & Nephrology | Vaccines